Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Inspira Technologies VORTX Device A Groundbreaking Advancement in Blood Oxygenation Technology

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
IT-Healthcare
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Inspira Technologies has made a groundbreaking achievement with its VORTX™ device on March 12, 2024, demonstrating exceptional performance in blood oxygenation and carbon dioxide removal. The device has successfully met all regulatory guidelines for blood oxygenation at various flow rates, maintaining a zero pressure gradient across the blood, leading to a decrease in markers of blood damage.

This significant milestone represents a major leap forward in the development of safer and more effective medical devices aimed at enhancing patient safety and improving clinical outcomes. Moreover, the VORTX™ technology has been granted a U.S. patent with 94% of its claims considered novel, highlighting its innovative approach to blood oxygenation that eliminates the need for fiber membranes and maintains crucial zero pressure gradient levels to minimize mechanical shear stress and reduce damage to blood components.

Inspira Technologies’ development of the VORTX™ Blood Oxygenator signifies a groundbreaking advancement in acute respiratory care, with the potential to revolutionize the perfusionist systems market valued at $1.16 billion. This cutting-edge technology is designed to efficiently saturate blood with oxygen and remove carbon dioxide, potentially enhancing hemodynamic performance and reducing oxygenator failure compared to traditional membrane-based systems.

In conclusion, Inspira Technologies’ VORTX™ device represents remarkable progress in medical technology, offering a promising solution for improving patient care and clinical outcomes through its innovative approach to blood oxygenation and carbon dioxide removal.

IINN Stock Soars by 3.83% on March 12, 2024: Positive Momentum and Indicators Signal Potential Growth

On March 12, 2024, IINN stock showed a strong performance, with the price of shares increasing by $0.07 since the market last closed. This represents a significant 3.83% rise in value, with the stock closing at $1.90. In pre-market trading, the stock continued to show positive momentum, rising by an additional $0.14. One key indicator of the stock’s performance is its position relative to its 52-week range and its 200-day simple moving average. IINN is currently trading in the middle of its 52-week range, indicating that it is neither at its highest nor lowest point over the past year. Additionally, the stock is trading above its 200-day simple moving average, which is a positive sign for investors as it suggests a longer-term upward trend in the stock price. The strong price momentum and positive indicators for IINN on March 12th may be attributed to a variety of factors, such as positive news or developments related to the company, favorable market conditions, or increased investor interest in the stock. Investors who were holding IINN shares would have likely seen a significant increase in the value of their investment on this day. It is important for investors to carefully monitor stock performance and market trends to make informed decisions about buying, selling, or holding onto their investments. While past performance is not indicative of future results, the strong performance of IINN on March 12th may be a positive sign for the stock’s future trajectory.

IINN Stock Performance: Positive Growth in Net Income and EPS Signals Progress in Financial Health

On March 12, 2024, investors closely watched the performance of IINN stock as the company’s financial data was released. According to CNN Money, the total revenue for IINN was currently unavailable, making it difficult to gauge the overall financial health of the company. However, the net income figures provided some insight into the company’s profitability.

IINN reported a net income of -$10.27 million over the past year, which was an improvement of 39.41% compared to the previous year. In the most recent quarter, the net income was -$2.42 million, showing a 14.2% increase from the previous quarter. Despite the negative net income figures, the positive growth rates indicated that the company was making progress in improving its financial performance.

Earnings per share (EPS) is another important metric that investors look at to evaluate a company’s profitability. IINN reported an EPS of -$0.95 over the past year, representing a 70.22% increase from the previous year. In the most recent quarter, the EPS was -$0.21, showing a 12.06% increase from the previous quarter. The positive growth in EPS indicated that the company was becoming more efficient in generating earnings for its shareholders.

Overall, the financial data released on March 12, 2024, showed that IINN was making strides in improving its profitability. Despite the lack of total revenue figures, the positive growth rates in net income and EPS were encouraging signs for investors. It will be interesting to see how the company continues to perform in the coming quarters and whether it can sustain its growth momentum. Investors will be keeping a close eye on IINN stock as more data becomes available to assess the company’s financial health.

Tags: IINN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Oppenheimer Analyst Reaffirms Outperform Rating for Olema Pharmaceuticals

Biotechnology Stock Exchange

Analyst Reiterates Buy Rating on ZyVersa Therapeutics with Revised Price Target

AI-Medical

IceCure Medical Ltd Receives Notice of Allowance for Groundbreaking Cryogen Flow Control Patent

Recommended

Hims & Hers Stock

Regulatory Storm Hits Hims & Hers as FDA Targets Marketing Claims

3 days ago
Berkshire Hathaway Stock

A New Era Dawns as Buffett Announces Berkshire Hathaway Exit

3 weeks ago
DouYu International Holdings Stock

DouYu’s Profit Turnaround Fails to Impress Skeptical Market

1 week ago
Desert Gold Ventures Stock

Desert Gold Ventures Stock: Mali Gold Project Sparks Investor Optimism

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Salesforce Leadership’s Stock Sales Raise Investor Concerns

Viking Therapeutics Approaches Critical Market Inflection Point

Uranium Energy Faces Investor Scrutiny Following Critical Short Report

Intel’s Nvidia Partnership Sparks Market Uncertainty

Immunocore Shares Face Technical Pressure Despite Solid Fundamentals

Opendoor Announces Sudden Departure of Finance Chief Amid Leadership Reshuffle

Trending

OFS Credit Stock
Analysis

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

by Andreas Sommer
September 22, 2025
0

Shares of OFS Credit came under significant selling pressure as the market reacted to disappointing third-quarter 2025...

Invesco S&P 500® Quality ETF Stock

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

September 22, 2025
Microsoft Stock

Microsoft Navigates AI Expansion Amid Immigration Policy Shift

September 22, 2025
Salesforce Stock

Salesforce Leadership’s Stock Sales Raise Investor Concerns

September 22, 2025
Viking Therapeutics Stock

Viking Therapeutics Approaches Critical Market Inflection Point

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • OFS Credit Faces Market Pressure Following Quarterly Earnings Miss
  • Navigating Market Volatility with the Invesco S&P 500 Quality ETF
  • Microsoft Navigates AI Expansion Amid Immigration Policy Shift

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com